Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Benicar HCT Tablets, Sankyo Pharma, NDA 21-532 6/5/03 6/9/03 6/9/03 9/10/03 Benicar (olmesartan medoxomil) Tablets, 5, 20, and 40 mg, Sankyo Pharma, NDA 21-286/S2 2/12/03 2/25/03 Benicar (olmesartan medoxomil) Tablets, 5, 20, and 40 mg, Sankyo Pharma, NDA 21-286/S1 10/25/02 10/28/02 Benicar (olmesartan medoxomil) Tablets, 5, 20, and 40 mg, Sankyo Pharma, NDA 21-286 | Benicar (olmesartan medoxomil) Tablets, Sankyo Pharma Inc., Labeling Revision | Benicar HCT (olmesartan medoxomil/hydrochlorothiazide) Tablets, Sankyo Pharma Inc., Labeling Revision | Benicar (olmesartan medoxomil) Tablets, Sankyo Pharma, Inc., Labeling Revision | Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) Tablets, Sankyo Pharma, Inc., Labeling Revision | AZOR (amlodipine and olmesartan medoxomil) Tablets, Daiichi Sankyo, Approval | Benicar (olmesartan medoxomil) Tablets, Daiichi Sankyo Inc., Labeling Revision | Benicar HCT (olmesartan medoxomil/hydrochlorothiazide) Tablets, Daichi Sankyo, Labeling Revision | Olmesartan Medoxomil Tablets, Mylan Pharma, Tentative Approval | Azor (amlodipine besylate and olmesartan medoxomil) Tablets, Daiichi Sankyo, Inc., Labeling Revision | Olmesartan Medoxomil and Hydrochlorothiazide Tablets, Mylan Pharmaceuticals Inc., Tentative Approval | Azor (amlodipine besylate and olmesartan medoxomil) Tablets, Daiichi Sankyo Pharma Development, New or Modified Indication | Olmesartan Medoxomil Tablets, Sandoz Inc., Tentative Approval | Benicar (olmesartan medoxomil) Tablets, Daiichi Sankyo, Inc., Efficacy Supplement | Tribenzor (olmesartan medoxomil, amlodipine and hydrochlorothiazide) Tablets, Daiichi Sankyo, Inc., Approval | Tribenzor (olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide) Tablets, Daiichi Sankyo, Inc., Labeling Revision | Olmesartan Medoxomil and Hydrochlorothiazide Tablets, Mylan Pharmaceuticals Inc., Tentative Approval | Benicar HCT (olmesartan medoxomil and hydrochlorothiazide) Tablets, Daiichi Sankyo, Labeling Revision | Azor (amlodipine besylate and olmesartan medoxomil) Tablets, Daiichi Sankyo, Inc., Labeling Revision | Benicar (olmesartan medoxomil) Tablets, Daiichi Sankyo, Labeling Revision | Benicar (olmesartan medoxomil) Tablets, Daiichi Sankyo Inc., Labeling Revision | Tribenzor (olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide) Tablets, Daiichi Sankyo, Inc., Labeling Revision | Tribenzor (olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide) Tablets, Daiichi Sankyo, Inc., Labeling Revision | Azor (amlodipine besylate and olmesartan medoxomil) Tablets, Daiichi Sankyo Inc., Labeling Revision | Tribenzor, amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil, Tablet; Oral, Daiichi Sankyo, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com